Exploring the molecular and immune landscape of cellular senescence in lung adenocarcinoma
Collectively, our findings underscore that ARRS through ARGs serves as a robust biomarker for the prognosis in LUAD.
Authors
- Miao Zhao (ORCID: https://orcid.org/0000-0002-4895-1177)
- Cong Wu (ORCID: https://orcid.org/0000-0002-9596-5344)
- Liang Cui (ORCID: https://orcid.org/0000-0002-4785-9678)
- Xiao Xiao (ORCID: https://orcid.org/0000-0002-9923-2500)
- Ting Yu (ORCID: https://orcid.org/0000-0003-4096-8975)
- Qiang Wu (ORCID: https://orcid.org/0000-0002-1733-1362)
- Hao Yu (ORCID: https://orcid.org/0000-0002-5370-9457)
- Xin Tan (ORCID: https://orcid.org/0009-0005-9741-6946)
- Jing Bai (ORCID: https://orcid.org/0000-0002-7011-5909)
- Kun Ru
- Wen T. An
- X Xia
- Xiang Liu (ORCID: https://orcid.org/0009-0007-2091-7624)
Institutions
- Central South University (CN)
- Shandong University (CN)
- Shandong Tumor Hospital (CN)
- Shandong First Medical University (CN)
- Hainan Medical University (CN)
- University of South China (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fimmu.2024.1347770
- Citations
- 4
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province